Eris Lifesciences Limited IPO
LISTEDEris Lifesciences Limited · Mainboard IPO · NSE · General
Price Band
₹603
Issue Size
N/A
Lot Size
N/A
About Eris Lifesciences Limited & Business Model
Eris Lifesciences Limited is an established Indian enterprise operating in the General sector. The company delivers specialized solutions, high-grade products, and technology-driven operations tailored to domestic and global market requirements. With an emphasis on operational excellence, regulatory compliance, and customer satisfaction, Eris Lifesciences Limited has developed an expansive client footprint and robust supply chain network.
Business Operations & Revenue Model
Eris Lifesciences Limited operates a scalable business model focused on value creation within General. Revenue is generated through primary product sales, long-term service contracts, B2B distribution networks, and key institutional partnerships. The business leverages automated manufacturing facilities, strict quality control systems, and strategic sourcing to maintain competitive margins and reliable service delivery.
Products & Key Services
1. Core Product & Service Offerings: Comprehensive product lines engineered for General standards. 2. Customized Solutions: Bespoke product configurations designed to meet specific B2B and institutional client specifications. 3. After-Market & Value-Added Services: Dedicated maintenance, technical support, and supply chain fulfillment services.
Promoters & Corporate Leadership
Eris Lifesciences Limited is led by experienced promoters with extensive industry track records and strategic governance capabilities. The leadership team brings multi-decade experience across operations, commercial strategy, corporate administration, and fiscal management.
Objects of the Issue (IPO Objectives)
The company proposes to utilize the Net Fresh Issue proceeds for the following primary objectives: 1. Funding capital expenditure requirements for expanding operational infrastructure and technology upgrades. 2. Meeting working capital requirements to support continuous business expansion. 3. Prepayment or repayment of certain outstanding borrowings to optimize capital structure. 4. General corporate purposes and strategic growth initiatives.
IPO Details & Terms
Strengths & Risks
✅ Strengths
- •Established market presence and strong brand recognition in General.
- •Integrated operational capabilities with focus on quality assurance and efficiency.
- •Diversified customer base reducing revenue concentration risk.
- •Experienced promoter and management team with strong domain expertise.
- •Scalable operational architecture positioned for future expansion.
⚠️ Risks
- •Fluctuations in key raw material availability and pricing could impact gross operating margins.
- •Dependency on third-party logistics and supply chain partners for timely distribution.
- •Intense market competition from both domestic established players and new entrants in General.
- •Regulatory changes or macroeconomic shifts affecting industry demand cycles.
- •Working capital intensive business operations requiring consistent cash flow management.
🚀 Opportunities
- •Expansion into high-growth regional and export markets.
- •Introduction of innovative product lines targeting evolving customer preferences in General.
- •Operational efficiency improvements through increased automation and digital integration.
Frequently Asked Questions
What is Eris Lifesciences Limited IPO?
Eris Lifesciences Limited IPO is an IPO by Eris Lifesciences Limited (General sector). The issue price is ₹603 with a lot size of N/A shares.
What is the minimum investment for Eris Lifesciences Limited IPO?
The minimum investment for Eris Lifesciences Limited IPO is approximately N/A (1 lot of N/A shares at ₹603 upper price band).
When is the Eris Lifesciences Limited IPO allotment?
Allotment date not yet announced.
When does Eris Lifesciences Limited IPO list?
Eris Lifesciences Limited IPO is scheduled to list on 29 Jun 2017.
Key Dates
IPO Rating
GMP (Grey Market Premium) is an unofficial, unregulated indicator. It does not guarantee the listing price. All IPO information is for educational purposes only. Verify from official SEBI/NSE/BSE sources.